Israel · Delayed Price · Currency is ILS · Price in ILA BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of ILS 1.93 billion. The enterprise value is 1.74 billion.
| Market Cap | 1.93B |
| Enterprise Value | 1.74B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 40.03 million shares outstanding. The number of shares has increased by 13.91% in one year.
| Current Share Class | 40.03M |
| Shares Outstanding | 40.03M |
| Shares Change (YoY) | +13.91% |
| Shares Change (QoQ) | +7.02% |
| Owned by Insiders (%) | 17.30% |
| Owned by Institutions (%) | 25.86% |
| Float | 27.78M |
Valuation Ratios
The trailing PE ratio is 82.99 and the forward PE ratio is 53.06.
| PE Ratio | 82.99 |
| Forward PE | 53.06 |
| PS Ratio | 11.59 |
| PB Ratio | 8.27 |
| P/TBV Ratio | 8.27 |
| P/FCF Ratio | 39.97 |
| P/OCF Ratio | 34.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 92.90, with an EV/FCF ratio of 35.95.
| EV / Earnings | 71.88 |
| EV / Sales | 10.43 |
| EV / EBITDA | 92.90 |
| EV / EBIT | 125.96 |
| EV / FCF | 35.95 |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.73 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | 0.45 |
| Interest Coverage | 2.77 |
Financial Efficiency
Return on equity (ROE) is 11.18% and return on invested capital (ROIC) is 45.57%.
| Return on Equity (ROE) | 11.18% |
| Return on Assets (ROA) | 2.60% |
| Return on Invested Capital (ROIC) | 45.57% |
| Return on Capital Employed (ROCE) | 4.77% |
| Weighted Average Cost of Capital (WACC) | 5.20% |
| Revenue Per Employee | 1.29M |
| Profits Per Employee | 187,202 |
| Employee Count | 120 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, BrainsWay has paid 430,380 in taxes.
| Income Tax | 430,380 |
| Effective Tax Rate | 1.75% |
Stock Price Statistics
The stock price has increased by +192.36% in the last 52 weeks. The beta is 0.14, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +192.36% |
| 50-Day Moving Average | 4,149.18 |
| 200-Day Moving Average | 3,066.53 |
| Relative Strength Index (RSI) | 62.85 |
| Average Volume (20 Days) | 86,504 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BrainsWay had revenue of ILS 166.49 million and earned 24.15 million in profits. Earnings per share was 0.58.
| Revenue | 166.49M |
| Gross Profit | 125.56M |
| Operating Income | 13.78M |
| Pretax Income | 24.58M |
| Net Income | 24.15M |
| EBITDA | 16.31M |
| EBIT | 13.78M |
| Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 215.83 million in cash and 21.73 million in debt, with a net cash position of 194.10 million or 4.85 per share.
| Cash & Cash Equivalents | 215.83M |
| Total Debt | 21.73M |
| Net Cash | 194.10M |
| Net Cash Per Share | 4.85 |
| Equity (Book Value) | 233.24M |
| Book Value Per Share | 5.96 |
| Working Capital | 195.52M |
Cash Flow
In the last 12 months, operating cash flow was 55.75 million and capital expenditures -7.46 million, giving a free cash flow of 48.29 million.
| Operating Cash Flow | 55.75M |
| Capital Expenditures | -7.46M |
| Depreciation & Amortization | 2.34M |
| Net Borrowing | -2.46M |
| Free Cash Flow | 48.29M |
| FCF Per Share | 1.21 |
Margins
Gross margin is 75.42%, with operating and profit margins of 8.28% and 14.50%.
| Gross Margin | 75.42% |
| Operating Margin | 8.28% |
| Pretax Margin | 14.76% |
| Profit Margin | 14.50% |
| EBITDA Margin | 9.80% |
| EBIT Margin | 8.28% |
| FCF Margin | 29.01% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.91% |
| Shareholder Yield | -13.91% |
| Earnings Yield | 1.25% |
| FCF Yield | 2.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2011. It was a reverse split with a ratio of 0.25.
| Last Split Date | May 22, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
BrainsWay has an Altman Z-Score of 3.73 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.73 |
| Piotroski F-Score | 5 |